Cart
sales@molnova.com
Oxypeucedanin hydrate
CAS No. 2643-85-8
Oxypeucedanin hydrate( —— )
Catalog No. M18330 CAS No. 2643-85-8
Oxypeucedanin hydrate exhibits carbohydrate metabolizing enzymes inhibitory effect.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 72 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameOxypeucedanin hydrate
-
NoteResearch use only, not for human use.
-
Brief DescriptionOxypeucedanin hydrate exhibits carbohydrate metabolizing enzymes inhibitory effect.
-
DescriptionOxypeucedanin hydrate has antioxidant activity. Oxypeucedanin hydrate is an antimutagenic agent. Oxypeucedanin hydrate exhibits carbohydrate metabolizing enzymes inhibitory effect.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetEpigenetic Reader Domain
-
RecptorAntioxidant
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2643-85-8
-
Formula Weight304.29
-
Molecular FormulaC16H16O6
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (328.63 mM)
-
SMILESCC(C)(C(COC1=C2C=CC(=O)OC2=CC3=C1C=CO3)O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
JWG-071
JWG-071, the first reported chemical probe for ERK5 kinase selectivity, is a BET-selective inhibitor with a 1 μM BRD4 IC that enhances both ERK5 activity and BRD4 selectivity.
-
RVX-208
RVX-208 is a potent BET bromodomain inhibitor with IC50 of 0.510 μM for BD2 in a cell-free assay, about 170-fold selectivity over BD1. Phase 2.
-
WAY-309060
WAY-309060 is a BRD4 small molecule inhibitor with antitumor activity.
